Human medicines European public assessment report (EPAR): Ibrance, palbociclib, Date of authorisation: 09/11/2016, Revision: 24, Status: Authorised

Patients and consumers

Referral: Mysimba, naltrexone,bupropion Article 20 procedures European Commission final decision, 27/03/2025, 22/05/2025, 03/06/2025

Questions and answers on the refusal of the marketing authorisation for Atropine sulfate FGK (atropine sulfate)

Human medicines European public assessment report (EPAR): Zeffix, lamivudine, Date of authorisation: 29/07/1999, Revision: 31, Status: Authorised

Clinical Trials Information System (CTIS): Information day, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 22 May 2025, 12:30 (CEST) to 22 May 2025, 17:30 (CEST)

Human medicines European public assessment report (EPAR): Cholestagel, colesevelam, Date of authorisation: 09/03/2004, Revision: 26, Status: Authorised

European Medicines Agency decision CW/0001/2025 of 2 June 2025 on class waivers in accordance with Regulation EC No 1901-2006 of the European Parliament and of the Council

Class waivers

EMA/PDCO summary report on the review of the list of granted Class Waivers 2 June 2025